{"id":913578,"date":"2025-11-25T08:40:33","date_gmt":"2025-11-25T13:40:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/"},"modified":"2025-11-25T08:40:33","modified_gmt":"2025-11-25T13:40:33","slug":"integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/","title":{"rendered":"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access"},"content":{"rendered":"<h2>\nCompany to advance care through broader access to breadth of skin substitutes across four unique technology platforms<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>PRINCETON, N.J., Nov.  25, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oihYz7jrbBxoqA-nnYYqPP4X20bKYJa96pLkq2KFhxr6Ck3u1gm5aH9YMAbB0oN3XmngBGK8R4trMdMh1DAowgOb0sWTYPoEIn0EtdsfKQm_UO-Gf_5woCLS8rVbwq_q\" rel=\"nofollow\" target=\"_blank\">Integra LifeSciences Holdings Corporation<\/a> (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare &amp; Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products \u2013 Integra<sup>\u00ae<\/sup> matrices, PriMatrix<sup>\u00ae<\/sup>, Cytal<sup>\u00ae<\/sup> and AmnioExcel<sup>\u00ae<\/sup> \u2013 utilize four different technology platforms for a wide range of complex cases in wound reconstruction. Integra\u2019s diverse portfolio spans multiple regulatory pathways positively impacted by these rulings\u2014including the FDA-approved (PMA), world-renowned flagship Integra<sup>\u00ae<\/sup> Dermal Regeneration Template.<\/p>\n<p>\u201cWe applaud CMS for taking this unprecedented step to meaningfully modernize payment structures that prioritize both innovation and improved outcomes,\u201d said Mojdeh Poul, president and chief executive officer, Integra LifeSciences. \u201cThe uniform reimbursement rate across care settings enables us to expand access to our diverse portfolio of products. No other company offers this breadth of cost-effective wound reconstruction solutions backed by science, supported by clinical evidence, and aligned to the reimbursement changes.\u201d<\/p>\n<p>\u201cThis is a pivotal advancement for our industry and the patients we serve,\u201d said Robert T. Davis, Jr., executive vice president and president of Integra\u2019s Tissue Technologies division. \u201cWith a robust commercial footprint already established in the hospital setting, we are poised to make a lasting impact as the procedural landscape evolves. We are also expanding our commercial presence across the continuum of care to benefit as many patients as possible. We believe the new policy will reward innovation, quality, and patient outcomes \u2013 areas where Integra has consistently led.\u201d<\/p>\n<p>\n        <strong>About Integra<\/strong>\n      <\/p>\n<p>Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies is trusted by healthcare professionals to deliver transformative care. For the latest news and information about Integra and its products, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_VmhQADI0-t582J3b74ssr9Odag_25DZg35eCCOI7RWbfE0iM8D81SmTJCy6YCcwHalb6UjyTkEHJjcl18EpYcQsUrLJCz-VnbUTjzEgg10=\" rel=\"nofollow\" target=\"_blank\">www.integralife.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, the commercial impact of the reimbursement rate decisions described herein as well as the availability, market potential, and therapeutic applications and efficacy of the Integra products described herein. There can be no assurance that the reimbursement rate decisions described herein will affect or alter the commercial performance or success of any Integra product. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect Integra\u2019s business which include but are not limited to: the Company\u2019s ability to predict accurately the demand for products and to develop strategies to successfully address relevant markets; physicians\u2019 willingness to adopt and third-party payers\u2019 willingness to provide reimbursement for the Company\u2019s products; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; global macroeconomic and political conditions; and the economic, competitive, governmental, technological and other risk factors and uncertainties identified under the headings \u201cRisk Factors\u201d and \u201cSpecial Note Regarding Forward-Looking Statements,\u201d included in Integra&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, and information contained in subsequent filings with the Securities and Exchange Commission. These forward-looking statements are made only as the date thereof, and Integra undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Chris Ward<br \/>(609) 772-7736<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=huC3Ko85HvBDl22EunSyu7TBg9aaRRA0ZUCeD-x2I6aqPPHvNSLv-DHpjPx9sTI6SjQ1N-fA2T3SWRBBf9SCGc5RuUrvJOrSnEJ9snQqefnLElYC7JKy_0hXCtW-P_L7\" rel=\"nofollow\" target=\"_blank\">chris.ward@integralife.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Laurene Isip<br \/>(609) 208-8121<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H8hLxz6RE4Mrwm6JlfsnCuSWbBoMaAtwGYUnSnMYe1ijpEMYBy2KnQqK8rKmTp1Si2pEJ4d7LEBtRiZsbJk62yi1YqXQsnsr2nRIG67ryQZh82Gik7pb3SptIYrg-uIa\" rel=\"nofollow\" target=\"_blank\">laurene.isip@integralife.com<\/a><\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WnHuqH7pzP2DnruxQ4hXJqrEpczhZCJuxSiwBVvCOnSZsIiV5Ty_jD0PdjrFYsTWqT916-ARtQc67WcHc9dNwmjUk7ZOnGLfnwtsFlWMsYlHwDuBjU0ECdczhGTZKI32BOGukZEHzzIwgFFmgXTsCSZGjtL0fg-_Q_uTqNuJ0aGX5sgy-lKEI_vuxGv2WoXXb88hi5eA3gsKKS-bKRxKqLpXguRLY-97VVhs4Fog3IG4UWBIrwF0pQJpOC2MzUjtuNhmFxJQth9PImbw_wkJ6A==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/a6593ae3-6b6d-467d-8cf8-1a5cd716d290<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTQ3MjYwYzEtYTY3MS00YjlhLWFkMjYtNzJmNTAwMTNmZWNiLTEwMTc3OTEtMjAyNS0xMS0yNS1lbg==\/tiny\/Integra-LifeSciences-Holdings-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare &amp; Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products \u2013 Integra\u00ae matrices, PriMatrix\u00ae, Cytal\u00ae and AmnioExcel\u00ae \u2013 utilize four different technology platforms for a wide range of complex cases in wound reconstruction. Integra\u2019s diverse portfolio spans multiple regulatory pathways positively impacted &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913578","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare &amp; Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products \u2013 Integra\u00ae matrices, PriMatrix\u00ae, Cytal\u00ae and AmnioExcel\u00ae \u2013 utilize four different technology platforms for a wide range of complex cases in wound reconstruction. Integra\u2019s diverse portfolio spans multiple regulatory pathways positively impacted &hellip; Continue reading &quot;Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T13:40:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access\",\"datePublished\":\"2025-11-25T13:40:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/\"},\"wordCount\":688,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/\",\"name\":\"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=\",\"datePublished\":\"2025-11-25T13:40:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/","og_locale":"en_US","og_type":"article","og_title":"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Market Newsdesk","og_description":"Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare &amp; Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic tissue membranes, which are classified as skin substitutes by CMS, are included in the ruling. These products \u2013 Integra\u00ae matrices, PriMatrix\u00ae, Cytal\u00ae and AmnioExcel\u00ae \u2013 utilize four different technology platforms for a wide range of complex cases in wound reconstruction. Integra\u2019s diverse portfolio spans multiple regulatory pathways positively impacted &hellip; Continue reading \"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-25T13:40:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access","datePublished":"2025-11-25T13:40:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/"},"wordCount":688,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/","name":"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=","datePublished":"2025-11-25T13:40:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTc5MCM3MjkxMzQ1IzIwMDYyMTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integra-lifesciences-welcomes-policy-advancements-supporting-medicare-beneficiary-access\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913578"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913578\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}